{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:54:57Z","timestamp":1775487297530,"version":"3.50.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004836","name":"Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["8020-00157B"],"award-info":[{"award-number":["8020-00157B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R209-2015-2774"],"award-info":[{"award-number":["R209-2015-2774"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008361","name":"Scleroseforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008270","name":"Warwara Larsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004954","name":"Augustinus Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005747","name":"A.P. M\u00f8ller og Hustru Chastine Mc-Kinney M\u00f8llers Fond til almene Formaal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005747","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>The pathological hallmark of multiple sclerosis (MS) is the formation of multifocal demyelinating lesions in the central nervous system (CNS). Stimulation of innate receptors has been shown to suppress experimental autoimmune encephalomyelitis (EAE), an MS-like disease in mice. Specifically, targeting Toll-like receptor 9 (TLR9) and NOD-like receptor 2 (NOD2) significantly reduced disease severity. In the present work we have developed a novel focal EAE model to further study the effect of innate signaling on demyelinating pathology. Focal lesions were induced by stereotactic needle insertion into the corpus callosum (CC) of mice previously immunized for EAE. This resulted in focal pathology characterized by infiltration and demyelination in the CC. We find that intrathecal delivery of MIS416, a TLR9 and NOD2 bispecific innate ligand, into the cerebrospinal fluid reduced focal lesions in the CC. This was associated with upregulation of type I and II interferons, interleukin-10, arginase-1, CCL-2 and CXCL-10. Analysis of draining cervical lymph nodes showed upregulation of type II interferons and interleukin 10. Moreover, intrathecal MIS416 altered the composition of early CNS infiltrates, increasing proportions of myeloid and NK cells and reducing T cells at the lesion site. This study contributes to an increased understanding of how innate immune responses can play a protective role, which in turn may lead to additional therapeutic strategies for the prevention and treatment of demyelinating pathologies.<\/jats:p>","DOI":"10.3389\/fnins.2021.682451","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T05:38:25Z","timestamp":1622698705000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Innate Signaling in the CNS Prevents Demyelination in a Focal EAE Model"],"prefix":"10.3389","volume":"15","author":[{"given":"Magdalena","family":"Dubik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Marczynska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlene T.","family":"M\u00f8rch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gill","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirstine Nolling","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Wlodarczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Khorooshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3389\/fimmu.2015.00492","article-title":"Stage-specific role of interferon-gamma in experimental autoimmune encephalomyelitis and multiple sclerosis.","volume":"6","author":"Arellano","year":"2015","journal-title":"Front. Immunol."},{"key":"B2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.nurt.2007.07.001","article-title":"Interferon-beta treatment for multiple sclerosis.","volume":"4","author":"Bermel","year":"2007","journal-title":"Neurotherapeutics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.humimm.2016.05.024","article-title":"Myeloid derived suppressor cells and autoimmunity.","volume":"77","author":"Boros","year":"2016","journal-title":"Hum. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jneuroim.2015.10.011","article-title":"Lipoic acid reduces inflammation in a mouse focal cortical experimental autoimmune encephalomyelitis model.","volume":"289","author":"Chaudhary","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"B5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis.","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bbi.2016.04.013","article-title":"Arginase-1 is expressed exclusively by infiltrating myeloid cells in CNS injury and disease.","volume":"56","author":"Greenhalgh","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/msj.20246","article-title":"Axonal damage in multiple sclerosis.","volume":"78","author":"Haines","year":"2011","journal-title":"Mt. Sinai J. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e45860","DOI":"10.1371\/journal.pone.0045860","article-title":"Treatment of autoimmune inflammation by a TLR7 ligand regulating the innate immune system.","volume":"7","author":"Hayashi","year":"2012","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1096\/fj.05-5465com","article-title":"The neuronal chemokine CX3CL1\/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system.","volume":"20","author":"Huang","year":"2006","journal-title":"FASEB J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s0022-510x(97)00080-4","article-title":"Monoclonal remyelination-promoting natural autoantibody SCH 94.03: pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis.","volume":"150","author":"Hunter","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"B11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40478-019-0876-2","article-title":"Innate signaling within the central nervous system recruits protective neutrophils.","volume":"8","author":"Khorooshi","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","article-title":"Multiple sclerosis: experimental models and reality.","volume":"133","author":"Lassmann","year":"2017","journal-title":"Acta Neuropathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview.","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1172\/jci31254","article-title":"A little stress is good: IFN-gamma, demyelination, and multiple sclerosis.","volume":"117","author":"Lees","year":"2007","journal-title":"J. Clin. Invest."},{"key":"B15","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/cns.12289","article-title":"In vivo administration of TLR9 agonist reduces the severity of experimental autoimmune encephalomyelitis. the role of plasmacytoid dendritic cells and B lymphocytes.","volume":"20","author":"Longhini","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"B16","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41467-017-01484-6","article-title":"Outflow of cerebrospinal fluid is predominantly through lymphatic vessels and is reduced in aged mice.","volume":"8","author":"Ma","year":"2017","journal-title":"Nat. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1093\/brain\/awl135","article-title":"A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination.","volume":"129","author":"Merkler","year":"2006","journal-title":"Brain"},{"key":"B18","doi-asserted-by":"crossref","first-page":"e12963","DOI":"10.1111\/sji.12963","article-title":"Protective roles for myeloid cells in neuroinflammation.","volume":"92","author":"Owens","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/ni.3703","article-title":"Ontogeny and homeostasis of CNS myeloid cells.","volume":"18","author":"Prinz","year":"2017","journal-title":"Nat. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.tins.2016.07.001","article-title":"How do meningeal lymphatic vessels drain the CNS?","volume":"39","author":"Raper","year":"2016","journal-title":"Trends Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3389\/fimmu.2014.00532","article-title":"Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages.","volume":"5","author":"Rath","year":"2014","journal-title":"Front. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41586-020-03116-4","article-title":"Gut-licensed IFN\u03b3(+) NK cells drive LAMP1(+)TRAIL(+) anti-inflammatory astrocytes.","volume":"590","author":"Sanmarco","year":"2021","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1742-2094-9-104","article-title":"IFN-\u03b3 protects from lethal IL-17 mediated viral encephalomyelitis independent of neutrophils.","volume":"9","author":"Savarin","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/jcbfm.2015.103","article-title":"Arginase I release from activated neutrophils induces peripheral immunosuppression in a murine model of stroke.","volume":"35","author":"Sippel","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s40425-017-0308-4","article-title":"Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.","volume":"5","author":"Steggerda","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"B26","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jaci.2019.03.008","article-title":"Toll-like receptor 9-dependent interferon production prevents group 2 innate lymphoid cell-driven airway hyperreactivity.","volume":"144","author":"Thio","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"696","DOI":"10.4049\/jimmunol.1801462","article-title":"Treatment of experimental autoimmune encephalomyelitis by sustained delivery of low-dose IFN-\u03b1.","volume":"203","author":"Vasquez","year":"2019","journal-title":"J. Immunol."},{"key":"B28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41598-017-18543-z","article-title":"Innate IFN-\u03b3 ameliorates experimental autoimmune encephalomyelitis and promotes myeloid expansion and PDL-1 expression.","volume":"8","author":"White","year":"2018","journal-title":"Sci Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jneuroim.2005.02.011","article-title":"Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis.","volume":"163","author":"Xu","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"B30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1523\/ENEURO.0435-17.2018","article-title":"The extracellular matrix and remyelination strategies in multiple sclerosis.","volume":"5","author":"You","year":"2018","journal-title":"eNeuro"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1084\/jem.186.10.1677","article-title":"Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells.","volume":"186","author":"Zhang","year":"1997","journal-title":"J. Exp. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1172\/jci31860","article-title":"Yin and yang interplay of IFN-gamma in inflammation and autoimmune disease.","volume":"117","author":"Zhang","year":"2007","journal-title":"J. Clin. Invest."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2021.682451\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T05:38:36Z","timestamp":1622698716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2021.682451\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,3]]},"references-count":32,"alternative-id":["10.3389\/fnins.2021.682451"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2021.682451","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,3]]},"article-number":"682451"}}